Q2 2023 · 13F-HR
Novo Holdings A/Sholdings as filed
Filed 2023-08-14 · accession 0000950123-23-007714
$1.29B
Reported value
41
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N07059210 | ASML | ASML HOLDING N V | $143.3M | 11.1% | 197,760 | Common | SOLE |
| 79466L302 | CRM | SALESFORCE.COM, INC. | $112.1M | 8.66% | 530,500 | Common | SOLE |
| 51655R101 | — | LANZATECH GLOBAL INC | $108.0M | 8.35% | 15,814,845 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $75.2M | 5.81% | 3,377,768 | Common | SOLE |
| 874039100 | TSM | TAIWAN SEMICONDUCTOR MFG LTD | $71.7M | 5.54% | 710,780 | Common | SOLE |
| 12685J105 | CABO | CABLE ONE INC | $61.8M | 4.78% | 94,103 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE, INC. | $48.4M | 3.74% | 1,090,772 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $47.1M | 3.64% | 6,071,703 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $43.6M | 3.37% | 1,684,193 | Common | SOLE |
| 037833100 | AAPL | APPLE INC | $43.0M | 3.32% | 221,460 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $42.2M | 3.26% | 845,000 | Common | SOLE |
| 01609W102 | BABA | ALIBABA GROUP HLDG LTD | $41.7M | 3.23% | 500,827 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $34.7M | 2.68% | 400,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX, INC. | $31.6M | 2.44% | 1,000,000 | Common | SOLE |
| 81181C104 | — | SEAGEN INC. | $30.8M | 2.38% | 159,986 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $28.4M | 2.19% | 448,804 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $28.3M | 2.18% | 1,339,304 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $26.3M | 2.03% | 2,095,900 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $22.5M | 1.74% | 118,383 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $21.9M | 1.69% | 2,000,000 | Common | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $21.8M | 1.69% | 3,330,377 | Common | SOLE |
| 112585104 | — | BROOKFIELD ASSET MGMT INC | $20.5M | 1.58% | 627,207 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $20.1M | 1.56% | 1,329,325 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $19.8M | 1.53% | 1,100,000 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $18.3M | 1.41% | 920,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $18.1M | 1.40% | 1,000,000 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $14.5M | 1.12% | 6,722,336 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $12.4M | 0.96% | 2,187,999 | Common | SOLE |
| 82710M100 | SILKUSD | SILK RD MED INC | $10.8M | 0.84% | 333,884 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $10.6M | 0.82% | 32,500 | Common | SOLE |
| 23284P103 | — | CYTEIR THERAPEUTICS INC | $9.5M | 0.74% | 3,662,636 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $9.4M | 0.72% | 500,000 | Common | SOLE |
| 89455T109 | TMCI | TREACE MED CONCEPTS INC | $9.2M | 0.71% | 360,000 | Common | SOLE |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $7.3M | 0.56% | 1,126,915 | Common | SOLE |
| 36338D108 | GRTX | GALERA THERAPEUTICS INC | $6.6M | 0.51% | 2,100,000 | Common | SOLE |
| 449778109 | IOBTQ | IO BIOTECH INC | $6.4M | 0.50% | 3,277,932 | Common | SOLE |
| 36322Q107 | GLTOUSD | GALECTO INC | $6.3M | 0.49% | 2,497,791 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $4.9M | 0.38% | 2,400,000 | Common | SOLE |
| 49705R105 | KNTEUSD | KINNATE BIOPHARMA INC | $2.5M | 0.19% | 815,707 | Common | SOLE |
| 57142B104 | MQ | MARQETA INC | $2.2M | 0.17% | 441,558 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $679,908 | 0.05% | 468,902 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.